Migraine, a debilitating neurological condition, affects millions of people worldwide, creating a significant demand for effective treatments. The migraine drugs market is expected to witness substantial growth in 2024, driven by increasing awareness, advancements in drug development, and the growing prevalence of the condition. Market Overview In 2024, the global migraine drugs market is projected to expand significantly. Migraine medications are crucial for managing symptoms and reducing the frequency of attacks. As the understanding of migraines evolves, new drug formulations and treatment options are entering the market. This has spurred innovation and competition among pharmaceutical companies, particularly in the areas of acute and preventive treatments. Key Drivers of Market Growth Several factors contribute to the growth of the migraine drugs market. First, there is a rising awareness of migraine as a medical condition, leading to more diagnoses and, subsequently, a high...